1-4 of 4
Yoichi Tatsumi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Baseline PET-Derived Metabolic Tumor Volume Metrics Predict Progression-Free and Overall Survival in DLBCL after First-Line Treatment: Results from the Phase 3 GOYA Study

Lale Kostakoglu, Maurizio Martelli, Laurie H. Sehn, MDMPH, David Belada, Angelo-Michele Carella, Neil Chua, Eva Gonzalez-Barca, Xiaonan Hong, Antonio Pinto, MD, Yuankai Shi, Yoichi Tatsumi, Günter Fingerle-Rowson, Andrea Knapp, Federico Mattiello, Tina Nielsen, Gila Sellam, Denis Sahin, Umberto Vitolo, MD, Marek Trněný, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 824.
https://doi.org/10.1182/blood.V130.Suppl_1.824.824
Published: 2017
Journal Articles

Phase I/II Multicenter Study of Romidepsin in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

Michinori Ogura, Dai Maruyama, MD PhD, Kensei Tobinai, MD, PhD, Toshiki Uchida, MD PhD, Kiyohiko Hatake, MD PhD, Masafumi Taniwaki, MD PhD, Kiyoshi Ando, MD PhD, Kunihiro Tsukasaki, MD, Takashi Ishida, MD PhD, Naoki Kobayashi, MD PhD, Kenichi Ishizawa, MD PhD, Yoichi Tatsumi, Koji Kato, MD PhD, Toru Kiguchi, MD PhD, Takayuki Ikezoe, MD PhD, Eric Laille, MS, Tokihiro Ro, MS, Hiromi Tamakoshi, MBA, Sanae Sakurai, MS, Tomoko Ohtsu, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3012.
https://doi.org/10.1182/blood.V128.22.3012.3012
Published: 2016
Journal Articles

Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Final Results from an Open-Label, Randomized Phase 3 Study (GOYA)

Umberto Vitolo, Marek Trněný, David Belada, Angelo M Carella, Neil Chua, Pau Abrisqueta, Judit Demeter, Ian W. Flinn, MD PhD, Xiaonan Hong, Won Seog Kim, Antonio Pinto, John M Burke, MD, Yuankai Shi, MD, Yoichi Tatsumi, Mikkel Oestergaard, Michael K Wenger, Günter Fingerle-Rowson, Olivier Catalani, Tina Nielsen, Maurizio Martelli, Laurie H Sehn, MD
Journal: Blood
Blood (2016) 128 (22): 470.
https://doi.org/10.1182/blood.V128.22.470.470
Published: 2016
Journal Articles

Cefozoplan, Meropenem, or Imipenem-Cilastatin Versus Cefepime As an Empirical Therapy in High Risk Febrile Neutropenic Adult Patients: A Multicenter Prospective Randomized Trial

Takahiko Nakane, MD, PhD, Toshiharu Tamaki, Kazuo Tamura, MD, PhD, Isao Yoshida, MD, Toshihiro Fukushima, MD, PhD, Yoichi Tatsumi, MD, PhD, Yasunori Nakagawa, MD, Kazuo Hatanaka, MD, Tsutomu Takahashi, MD, PhD, Nobu Akiyama, MD, PhD, Mitsune Tanimoto, MD, PhD, Kazuma Ohyashiki, MD, PhD, Akio Urabe, MD, PhD, Tohru Masaoka, MD, PhD, Akihisa Kanamaru, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1037.
https://doi.org/10.1182/blood.V120.21.1037.1037
Published: 2012